Redwire was assembled in 2020 by AE Industrial Partners — a rollup of two niche space-heritage shops (Adcole Space and Deep Space Systems) that had been quietly building satellite buses, deployable structures, and in-space manufacturing payloads for programs the generalist desk had never heard of. AE took it public via SPAC in September 2021, before the constituent businesses had ever been valued together as a single space-prime. Then in January 2025 the company bought Edge Autonomy for $925M — $150M cash, $775M stock, 189% YoY dilution — and inherited the Penguin UAS, the small unmanned aircraft Ukrainian forces have been flying against Russian targets since 2022. That was the inflection. A sub-scale orbital-infrastructure name became a multi-domain defense-tech entity overnight, and in January 2026 the Pentagon's Golden Dome architecture pulled Redwire into the institutional defense-tech conversation for the first time. Consensus is pricing the dilution and the Q1 EPS miss. What consensus is ignoring: a 1.92x book-to-bill on a record $498.1M backlog is the cleanest forward demand signal in small-cap defense-tech, and the body argues that signal is what the multiple should be tracking. Watch the next two prints.
Sources: fundamentals_report, investment_debate_state.bull_history, investment_debate_state.bear_history, final_trade_decision, analysis-state file full_states_log_2026-05-07.json; external — Adcole Space and Deep Space Systems 2020 merger, AE Industrial SPAC September 2021, Edge Autonomy acquisition January 2025, Penguin UAS Ukraine deployment, Golden Dome January 2026 inclusion.
Gaps: None — origin, inflection, and asymmetry beats all sourced from upstream content.
Portfolio Decision
Maintain RDW positions at 1-3% portfolio weight; do not initiate aggressively at $9.64 with the post-print snap-back unconfirmed and the AE Red Holdings lockup-driven supply overhang in early innings. The May 6 Q1 2026 print delivered the demand-side validation the bull case required (record $498.1M backlog, book-to-bill 1.92x, +57.9% YoY revenue, gross margin +1190 bps to 26.6%) but missed top-line consensus by 7.3% and bottom-line by 165%, while the company funded operations through a $530M follow-on equity raise that pushed share count up 25% in a single quarter on top of the +189% YoY dilution from the Edge Autonomy acquisition close. With beta of 2.42 and the next major catalysts (Q2 earnings August 5; FY27 budget operationalization September 30) inside 90-150 days, this is a high-volatility binary-event setup where position-sizing discipline matters more than directional conviction.
Redwire is the most operationally improved and most financially fragile name in the small-cap aerospace and defense complex as of May 2026. The Q1 print validated the bull case on every demand metric — record backlog, exceptional book-to-bill, 57.9% revenue growth, expanding gross margin — at a forward EV/Sales multiple (4.1x on the FY26 $475M midpoint guide) that is reasonable for a 50%+ grower in a Pentagon FY27 $1.5T budget cycle. The Edge Autonomy acquisition (closed mid-2025, $925M, $150M cash + $775M stock) gave RDW a combat-validated drone platform (Penguin UAS in Ukraine) and is the strategic foundation for Pentagon Group 2 UAS exposure. The Golden Dome inclusion in January 2026 (+29% session-day rally) and ongoing FY27 budget operationalization create a structural catalyst calendar.
Redwire's revenue is split across three customer segments: 46.9% national security (DoD, intelligence community, allied governments), 21.6% civil (NASA, ESA, civilian space), and 31.5% commercial (commercial satellite operators, station modules, in-space manufacturing). 41.6% of revenue is non-US, reflecting Edge Autonomy's European footprint and international space-program exposure. No single customer is disclosed at >10% of revenue, but the aggregate DoD exposure is the dominant single-event risk: discretionary appropriations, program-funding cycles, and contract-protest outcomes drive material variance.
Customer
% Revenue
Type
National Security (DoD + Intel + Allied Governments, aggregated)
46.9
Commercial (commercial satellite operators, station modules, in-space manufacturing)
31.5
Civil (NASA, ESA, civilian space agencies)
21.6
International (non-US revenue)
41.6
As of: 2025-12-31
Backlog & Book-to-Bill
Total Backlog$498.1M (record; disclosed in Q1 2026 earnings, May 6, 2026)2026-03-31
Book-to-Bill (Qtr)1.92xExpanding
Quarterly backlog (gold bars) with book-to-bill ratio (line; dashed marker at 1.0x).
Quarter
Backlog
Book-to-Bill
Q1 2025
305.0
None
Q2 2025
365.0
None
Q3 2025
392.0
None
Q4 2025
411.2
None
Q1 2026
498.1
1.92x
The backlog trajectory is unambiguously positive — $305M → $498.1M over four quarters represents 63% growth, and the explicit Q1 2026 B2B of 1.92x means orders received exceeded revenue recognized by nearly 2x in the quarter. This is the demand-side validation of the Edge Autonomy thesis and the Golden Dome umbrella inclusion. The execution risk is converting that backlog to revenue: at 1.92x B2B, RDW is implicitly capacity-constrained, and the operational question is whether manufacturing scale-up keeps pace. Historical precedent in small-cap aerospace and defense suggests that 1.5-2.0x B2B sustained for 4+ quarters is the threshold for re-rating, but execution slips can compress the multiple even as backlog grows. The next 2-3 quarters of book-to-bill are the leading indicator that matters most for the equity story.
Catalyst Calendar
Catalyst nodes are color-coded by impact (red=high, amber=medium, tan=low). Events grouped by quarter.
Research Manager
Investment Plan — Hold
Rationale:
The bull case clears all five items of the specificity bar — two dated catalysts (Q2 2026 earnings on August 5, 2026 and DoD FY27 Golden Dome task-order operationalization on September 30, 2026), customer-segment growth math anchored to a credible 0.5-2% capture rate of the $151B Golden Dome umbrella implying $300-400M cumulative through FY28, a budget-cycle reference (Pentagon FY27 $1.5T submission with explicit Golden Dome line items), a consolidation reference (Edge Autonomy acquisition closed mid-2025 at $925M with combat-validated drone IP), and a three-condition falsifiable kill-switch (FY26 revenue <$440M AND Q3 2026 B2B <1.3x AND further $200M+ equity raise). The operational data are genuinely impressive: Q1 2026 revenue +57.9% YoY, gross margin expanding 1190 bps YoY to 26.6%, record backlog of $498.1M with book-to-bill of 1.92x. At 4.1x forward EV/Sales for a 50%+ grower in a structural defense-tech tailwind environment, the multiple is reasonable.
But the bear is not strawmanning. The Q1 print missed top-line consensus by 7.3% and bottom-line consensus by 165%, the share count grew 189% year-over-year (66.3M → 191.9M end-2025) with another 25% incremental dilution in Q1 2026 from the $530M follow-on, the AE Red Holdings lockup-driven selling has begun (2.7M shares sold at ~$10.50/share in late April, which is roughly 3-4% of their estimated ~70-80M-share position), the 10-K disclosed material weaknesses in internal controls over financial reporting, and operating cash flow remained negative every quarter of 2025 and Q1 2026 — the dilution machine is structurally live. SDA Tranche 3 ($3.5B for 72 satellites) went to LMT, L3H, NOC, and RKLB on April 28, 2026 — RDW was not on the prime list. The bull's sub-tier-supplier framing is correct but unproven at the magnitude required to justify the bull math.
This is precisely the kind of high-volatility small-cap setup where institutional discipline argues against directional conviction in either direction. The fundamentals say "constructive on a 12-18 month horizon if execution holds." The financing and supply-overhang dynamics say "wait for Q2 confirmation." Position weight should be sized for asymmetric volatility (beta 2.42), not for high-conviction return expectations. Maintain existing position; do not initiate aggressively at $9.64; willing to accumulate on weakness toward $7.00-$7.50 if Q2 prints clean; trim into strength back above $13-$14 if reached without resolution of the AE Red lockup and the FY26 revenue trajectory.
Strategic Actions:
Existing holders: Maintain at prior conviction weight, capped at 3% portfolio. Do not exit on the post-print snap-back; the operational data justify holding the position. Accept 60-90 day event-risk dominance.
New investors: Establish a starter position only at 0.5-1% portfolio weight with explicit add levels at $7.50, $6.50, $5.50. Do not chase above $11.50 without a Q2 catalyst beat.
Risk management: Hard stop at $4.50 (below 52-week low). Position-sized to absorb a 30-40% drawdown without triggering forced liquidation, given beta of 2.42 and the binary-event setup.
Monitoring: Track three signals before August 1: (a) any specific Golden Dome task-order awards naming RDW, (b) further AE Red Holdings 13D/13G filings or 10b5-1 plan disclosures, (c) any pre-Q2 negative pre-announcement or guidance update.
Capital allocation: Sized as a high-conviction speculative position (3% max), not a core defense allocation (the mega-cap primes are still the core defense allocation).
Trader
Transaction Proposal — Hold
Action: Hold
Reasoning: The Research Manager's Hold rating reflects the right tension: a fundamentally improving operating engine (revenue +57.9% YoY, gross margin +1190 bps, backlog +63% in 4 quarters, book-to-bill 1.92x) trading at a reasonable 4.1x forward EV/Sales, against a financing structure that has diluted shares 189% year-over-year and a lockup-driven supply overhang from the Edge Autonomy stock-deal counterparties that is in the early innings of unwinding. The May 6 post-print intraday reversal ($8.65 → $9.64 on 30M shares) is constructive but unconfirmed; one good close does not undo a -56.7% drawdown from the 52-week high. Beta of 2.42 demands ATR-adjusted position-sizing discipline — this is not a name to chase or to aggressively short.
Entry Price: $7.50-$8.50 (accumulation zone, only on a re-test of prior support without a Q2 negative pre-announcement)
Position Sizing: 0.5-1% portfolio for new investors, 3% maximum for existing high-conviction holders. The beta-2.42 / cash-burn profile is incompatible with larger sizing in any institutional mandate.
FINAL TRANSACTION PROPOSAL: HOLD
Investment Debate
Bull Researcher
Round 1
The market is pricing Redwire as if the May 6 EPS miss invalidated the entire investment case, when in fact the print delivered the single most predictive forward indicator in defense-tech: a record backlog of $498.1M with a book-to-bill of 1.92x. That is the demand-side signal that overrides quarter-by-quarter execution noise, and it is currently being given away at 4.1x forward EV/Sales — a level inconsistent with a 50%+ revenue grower in a Pentagon-budget-cycle tailwind environment.
Five anchors. Two dated catalysts: (1) Q2 2026 earnings on August 5, 2026 — the first opportunity to validate that Q1 backlog momentum is converting to revenue, with the FY26 guide of $450-500M (midpoint $475M) requiring meaningful sequential acceleration; (2) DoD FY27 budget operationalization on September 30, 2026 — the first wave of Golden Dome task-order awards expected late Q3 2026 under the $151B umbrella RDW joined in January.
Customer-segment growth math. The DoD FY27 budget at $1.5T includes explicit Golden Dome line items. The Golden Dome program total addressable revenue over 5 years is $151B; tier-2 component suppliers like RDW typically capture 0.5-2% of an integrator-level umbrella, implying $750M-$3.0B of cumulative RDW addressable revenue from Golden Dome alone. At even 1% capture, the FY27-FY30 revenue impact is ~$300M-$400M cumulative, on top of an existing FY26 baseline of $475M. Combined with the Edge Autonomy drone platform addressable market (Pentagon Group 2 UAS spending ~$2-3B annually growing at 25%+), the $475M FY26 base could compound to $900M-$1.1B by FY28 at current capture rates. At 4-5x EV/Sales on that revenue, market cap would be $4.5B-$5.5B vs current $1.92B — a 2.3x-2.9x re-rating.
Budget-cycle reference: The Pentagon's FY27 budget submission of $1.5T (per the April 2026 Sirotin Intelligence Briefing) operationalizes Golden Dome at the line-item level for the first time. This is the start of a multi-year DoD POM cycle that runs through FY30 minimum. RDW is positioned as an established sub-tier component supplier within that umbrella.
Consolidation/capacity reference: The Edge Autonomy acquisition (closed mid-2025, $925M, $150M cash + $775M stock) is precisely the strategic consolidation that creates the demand pull. Edge Autonomy gave RDW a combat-validated drone platform (Penguin UAS deployed in Ukraine) without a multi-year internal R&D cycle. Pentagon procurement officers explicitly value combat-validated platforms — that's the underlying reason the book-to-bill jumped to 1.92x post-Edge.
Falsifiable kill-switch: If FY26 revenue lands below $440M (i.e., below the low end of the reaffirmed $450M-$500M guide) AND book-to-bill falls below 1.3x by the Q3 2026 print, the structural-growth thesis is broken.
The bear's strongest points are the EPS miss and the dilution. Both are real, but the dilution is already priced in — the stock is -56.7% off the 52-week high, $9.64 vs $22.25, while the operational data (revenue +57.9% YoY, gross margin 26.6% expanding 1190 bps YoY, backlog +63% in 4 quarters) has continued to inflect positively. The market is fading the operational data because of the financing data. That is the asymmetry — a fundamentally improving business at a multiple that prices a fundamentally deteriorating one.
Round 2
The bear's framing of the SDA Tranche 3 award as evidence of competitive exclusion is misreading the architecture of the program. Tranche 3 was a prime-integrator award for 72 missile-tracking satellites — that is a $50M+ per satellite procurement that requires multi-decade past-performance data. RDW was never positioned to compete at the prime level for a $3.5B award; that's not the lane. RDW's lane is sub-tier component supply — sensors, payloads, satellite-bus modifications, in-space-manufacturing capabilities — sold to the primes. So the bear's "RDW wasn't in the room" framing actually means "RDW was correctly positioned at the supplier tier." The relevant question is whether the prime-integrator awards translate into sub-tier component awards. The early answer is yes: the $20M order RDW disclosed in Q1 (Navy/Marine Corps Small Tactical UAS support) is exactly that kind of sub-tier translation.
On the dilution: the bear keeps cycling back to the share-count math without acknowledging that the equity issuance funded a transformational acquisition that changed the investment case. Pre-Edge Autonomy RDW was a sub-scale space-infrastructure niche play with $200M of revenue and no defense-tech exposure. Post-Edge it is a $475M-revenue, defense-tech-anchored company with combat-validated drone IP, exposure to the largest growing line item in the FY27 DoD budget (autonomous systems), and a book-to-bill validating the strategic move. The dilution is the price of the transformation; the question is whether the post-dilution earnings power justifies the implied per-share economics. At 4.1x forward EV/Sales on $475M, the math says yes if margin holds. The bear's "already-diluted is already-overvalued" framing requires you to believe that none of the operational improvements have intrinsic value.
On the AE Red sale: 2.7M shares is meaningful but not catastrophic — about 1.4% of the share count, executed at $10.50/share which is above current price. If AE Red were panicking, they would not have stopped at 2.7M. Insider lockup expirations are baked into the share-count math; the question is the velocity, and the absence of a 8-K filed disclosing a 10b5-1 plan with aggressive monthly liquidations suggests AE Red is opportunistic, not exiting.
On the ICFR material weaknesses: real but remediation-tractable. The 10-K explicitly identified the issues as integration-related and revenue-recognition-cutoff specific. These are auditable, fixable, and historically common in the first reporting period after a transformational acquisition. The remediation timeline is typically 4-8 quarters; by the FY26 10-K filing, the issue should be substantially closed.
Updated kill-switch: If FY26 revenue lands below $440M AND Q3 2026 book-to-bill falls below 1.3x AND a further $200M+ equity raise is announced, the thesis is broken. That is now a three-condition trigger — meaningful but credible.
Bear Researcher
Round 1
The bull is doing what bulls always do at this stage of a small-cap defense-tech cycle: citing backlog as if it were revenue and citing TAM math as if it were market share. Let me address each piece.
On backlog: yes, $498.1M is record, and yes, 1.92x is impressive. But Redwire has historically converted backlog at slow velocity, and the company is now a different entity than 18 months ago — Edge Autonomy integration adds operational complexity and customer-mix shift. The Q1 revenue miss of 7.3% versus consensus, despite the backlog at year-end being $411M (already above the run-rate revenue), is direct evidence of the conversion problem. Strong backlog with weak conversion is the worst pattern: it builds analyst expectations that the operational engine cannot sustain.
On the dilution: the bull says "already priced in." That's revisionist. Share count went from 66.3M at year-end 2024 to 191.9M at year-end 2025 — a 189% increase. Then another 25% incremental dilution in Q1 2026 ($530M follow-on). Per-share metrics have collapsed even as absolute revenue has grown. Book value per share has declined despite total stockholders' equity going from -$52M to $1,137M. You cannot rationalize away three rounds of equity issuance as "already priced in" when the company guided that further dilution may be needed to fund growth investment.
On the TAM math: the bull's "0.5-2% capture of the $151B Golden Dome umbrella" is the kind of TAM-times-share calculation that has destroyed more small-cap-defense investors than any other narrative. Look at the SDA Tranche 3 award on April 28, 2026: $3.5B for 72 satellites went to Lockheed Martin, L3Harris, Northrop Grumman, and Rocket Lab USA. RDW was not on the prime list. When the actual contract awards started coming in, RDW was not in the room. The Golden Dome umbrella inclusion is a vehicle — it is not awarded revenue. Until RDW shows specific task-order wins from this umbrella, the bull math is hopeful, not actionable.
On the bull's specificity bar attempt: 5 of 5 items technically present, but the quality of the items is uneven. The Q2 earnings catalyst is real and dated. The Golden Dome task-order catalyst is real but explicitly hopeful (no specific RDW task order has been disclosed). The customer-segment growth math relies on a 1% capture rate of the umbrella — which is above RDW's recent track record (zero specific Golden Dome task orders to date). The budget-cycle reference is real. The consolidation reference (Edge Autonomy) is the most compelling piece. The kill-switch is reasonable but generous — a 1.3x book-to-bill is still "structural growth" in defense parlance, so the kill-switch doesn't actually kill the thesis at the level set.
What the bull cannot answer:
AE Red Holdings sold 2.7M shares at $28.4M (~$10.50/share) in late April 2026 — the Edge Autonomy stock-deal counterparties are now selling. Lockup expirations are rolling. The supply pressure on the stock is structural and won't abate for at least 6-12 months as remaining Edge counterparties unlock.
Material weaknesses in ICFR disclosed in the 10-K. This is a Sarbanes-Oxley-flagged internal-controls problem in an aerospace/defense name with classified contract exposure. The remediation cost is unknown; the audit-fee inflation is certain; the reputational exposure with DoD program offices is non-trivial.
Operating cash flow was negative in every quarter of 2025 and Q1 2026. The company funds operations and growth via equity issuance, not internally generated cash. Until there is a credible path to operating cash flow positive, the dilution machine remains live.
Bear thesis: RDW drifts to $7.50-$8.50 over the next 90 days as the post-print snap-back fades and the dilution overhang reasserts. If Q2 misses revenue or book-to-bill drops below 1.5x, the stock retests the 52-week low at $4.87. Position size accordingly: this is a short-or-avoid name until the cash-burn arc inflects.
Round 2
of the SDA Tranche 3 framing is interesting but evasive. The question is not whether RDW could have been positioned for a $3.5B prime award — obviously not. The question is whether the sub-tier supplier model produces the revenue magnitudes that the bull math requires. To capture 1% of a $151B umbrella over 5 years, you need a sub-tier supplier capture rate of roughly 1.5-2% per task order, sustained across dozens of task orders. RDW has disclosed exactly one new contract in Q1: a $20M Navy/Marine Corps order. That's 0.013% of the $151B umbrella. The bull is asking the market to price in a 60-150x improvement in the disclosure rate over the next 18 months. That's a hopeful base case, not an obvious one.
On the transformation argument: yes, the Edge Autonomy acquisition changed the company. But the change is exactly what the dilution priced in, and the post-transformation operational data is mixed. Q1 revenue +57.9% YoY is good; Q1 revenue 7.3% below consensus is not. Gross margin expanding 1190 bps YoY is excellent; gross margin still being insufficient to cover SG&A and R&D is the more important fact. The bull is celebrating directional improvement on metrics that remain in the wrong absolute zone.
On AE Red: 2.7M shares is the first disclosed tranche. The Edge Autonomy stock consideration was $775M; AE Red and related entities received on the order of 70-80M shares in that consideration based on the deal-time stock price. The 2.7M sale is roughly 3.4-3.8% of their position. Lockup-expiration-driven selling of remaining 96%+ of the position is the structural overhang for the next 12-18 months. The bull cannot dismiss this as "opportunistic."
On the ICFR remediation: yes, common after acquisitions, yes, fixable. But you don't get DoD program-office trust by having ICFR material weaknesses. Classified-contract performance requires demonstrated financial-controls maturity. The competitive cost of the ICFR disclosure — at the margin, against bidders without ICFR issues — is non-zero and will not be visible in any quarterly press release.
Final bear position: Underweight or avoid. The downside is concrete (continued dilution, lockup-driven supply overhang, ICFR remediation cost, dependence on Golden Dome task-order disclosures that have not yet materialized) and the upside requires a sustained execution narrative that is not yet in evidence. Rating: Underweight at $9.64. Buy zone: $5.50-$6.50 if it gets there. Sell zone: $13-$15 if it gets there before the Q2 print.
Risk Assessment
Aggressive
Round 1
The trader's Hold leaves significant upside on the table in a name where the market is structurally mispricing the demand-side data. RDW just printed a record $498.1M backlog with a book-to-bill of 1.92x — these are the numbers small-cap defense investors wait years to see. Combined with gross margin expanding 1190 bps YoY to 26.6% and revenue growing 57.9% YoY, the operational engine is firing. At 4.1x forward EV/Sales, this is the cheapest entry into the post-Edge-Autonomy combined entity since the deal closed. The Conservative will lecture about beta and dilution; both are real, both are already in the price (-56.7% from the 52-week high tells you the dilution is discounted).
The post-print May 6 reversal — $8.65 → $9.64 on 30.2M shares (well above the 18M average) — is the kind of capitulation-and-snap-back signature you see at small-cap bottoms. The trader should be using $9-$10 as an accumulation zone, not a wait zone. A 1% portfolio entry here with a 1.5% add at $7.50 if it gets there gives you 2.5% positioning before Q2 in a name that could be 2-3x by FY27 if the Golden Dome task orders flow.
The bear's lockup-driven AE Red overhang is a concern but is also a known unknown. Lockup expirations are scheduled events, so the supply pressure can be modeled — at the rate of the late-April 2.7M sale, full unwind of an estimated 70-80M-share position would take 26-30 months at consistent velocity. By the time the lockup overhang clears, the operational engine will have already re-rated the stock or destroyed it. Waiting for the overhang to clear means buying at the higher post-rerate price.
Position move: Initiate 1% at $9-$10, add 1% at $7.50 if reached, with a hard stop at $4.50. The risk-reward is asymmetrically constructive over a 12-18 month horizon.
Round 2
The Conservative's "wait for $5.50-$6.50" framework is the kind of thinking that misses bottoms in small-cap defense-tech. The 52-week low at $4.87 was set in mid-2025, before the Edge Autonomy integration was complete and before the Golden Dome inclusion. The company is fundamentally different now than at the prior low; reaching $4.87 again would require a thesis-shattering event (failed Q2, new equity raise, contract loss) — three independent negatives, not one. Pricing in that conjunction as the base-case entry zone is overly defensive.
The lockup math is also being misframed. AE Red disposed of 2.7M shares over a multi-week window in April-May, indicating opportunistic price-conscious execution, not panic. If they had a calendar-mandated unwind, they would file the 10b5-1 plan and the disposition would be visible at scheduled intervals. The opportunistic pattern means the seller is balancing supply against price impact, which is bullish — they care about realized price, which means they will slow disposition into weakness.
On the Q1 EPS miss: GAAP EPS misses in companies with $35M+ of unusual items (Q4 2025 had -$35.8M of unusual items) are heavily noise-driven. The operational metrics — revenue, gross margin, backlog, book-to-bill — are the data the equity should be priced on. The market priced the EPS miss into the May 6 selloff and the operational data into the May 6 reversal. That is correct sequencing, and the next test is the Q2 print.
I move to upgrade the position-sizing: maintain Hold rating, but allow 1% add at $7.50-$8.00 with hard stop at $4.50. Risk-reward over 12-18 months remains constructive.
Conservative
Round 1
The Aggressive is treating beta of 2.42 as a feature when it is the most important risk factor in the entire setup. This is a name with an ATR of 4-5% per day, an annual price range of $4.87 to $22.25 (a 4.6x ratio), and a balance sheet that is structurally dependent on equity issuance to fund operations. None of those characteristics are conducive to "accumulate the dip" reasoning unless the dip is genuinely confirmed.
Look at the Q1 print itself. Revenue missed by 7.3%, EPS missed by 165%. This is not a name where execution is on rails. The bull narrative requires conversion of $498.1M backlog at a velocity that the company has not yet demonstrated. Strong backlog with weak conversion is the worst pattern in defense-tech, and small-cap names with that pattern routinely retest 52-week lows when the conversion-velocity disconnect becomes evident.
On the dilution: the Aggressive says "already in the price." That's not how serial dilution works. Each round of issuance creates a fresh anchor in the share count and resets the per-share economics. The $530M follow-on in Q1 was the third major equity raise in 18 months. The 10-K explicitly cites the possibility of further equity issuance to fund growth investments. Until cash burn inflects (no near-term visibility) or a credible debt-financing alternative emerges (none disclosed), the dilution machine is structurally live and represents a permanent overhang on the share price.
On the AE Red lockup: the Aggressive is dismissing this too lightly. 2.7M shares is the first disclosed tranche, executed at $10.50/share — above the current price. If the seller was opportunistic and price-conscious, the next tranches may execute at lower prices, creating self-reinforcing supply pressure. Calling this a "scheduled event you can model" misreads the asymmetry: lockup-driven selling provides supply on every rally and zero demand on every dip.
Position move: Do not add at current levels. Maintain Hold for existing positions only. New positions should wait for either (a) a confirmed Q2 beat establishing backlog conversion at the implied velocity, or (b) a re-test of $5.50-$6.50 with no catalyst-broken news. Hard stop on existing positions at $7.50.
Round 2
"operationally improving" with "investable at this price." The two are different concepts. RDW could continue improving operationally and the stock could still drop 30% over the next 6 months if the dilution machine reactivates or if the Q2 print has another revenue miss. The disconnect between operational data and stock-price behavior is the entire story of small-cap defense-tech in 2024-2026.
On the lockup: the Aggressive's "opportunistic = bullish" framing inverts the actual asymmetry. An opportunistic seller is one who maximizes realized value at each disposition window. As the stock drifts higher (e.g., on a Q2 beat), they accelerate disposition. As the stock drifts lower, they pause but resume on the next bounce. The supply pressure operates as a ceiling on every rally. That is structurally bearish, not bullish.
On the unusual-items defense of the EPS miss: yes, GAAP EPS includes noise. But the full-year FCF burn of -$120M is not noise — it is the structural cash demand of the operating model. Until that cash burn inflects, the equity-issuance probability remains elevated. The bull thesis requires not only operational execution but also financing discipline, and the latter has not yet been demonstrated.
I'll concede that buying $7.50 is a more efficient capital deployment than waiting for $5.50, conditional on the macro defense-tech tape remaining supportive. Updated position move: maintain Hold, do not add at current levels, allow opportunistic adds at $7.50-$8.00 only if (a) no negative Q2 pre-announcement and (b) no further AE Red 13D filings between now and the entry attempt. Hard stop at $5.50 (revised down from $7.50, recognizing the bull's point that the prior low was set in a different operational environment).
Neutral
Round 1
Both sides are partially right. The Aggressive is correct that the operational data justify holding — the bull case has not been broken. The Conservative is correct that the financing structure and beta profile justify caution on adding — the bear case has not been resolved. The dispute is about position-sizing and add-discipline, not about the directional Hold call.
The neutral resolution: the trader's Hold is correct, but the position sizing should reflect the binary-outcome distribution. Specifically, the next 90 days have three high-impact information events:
August 5 Q2 earnings — direct test of backlog conversion velocity, gross margin sustainability, and FY26 guide credibility.
September 30 DoD FY27 budget operationalization — first wave of Golden Dome task-order awards, where RDW either appears or does not.
Ongoing AE Red Holdings disclosures — any 13D/13G filing or 10b5-1 plan announcement signaling acceleration of the lockup unwind.
By the August 5 print, two of three information events resolve. The right pre-commitment plan:
Q2 revenue ≥$110M AND book-to-bill ≥1.5x AND no new dilution announced → upgrade to Overweight, add 0.5-1% in the $11-$13 zone
Q2 revenue $100-$109M OR book-to-bill 1.3-1.49x → maintain Hold, do not add
Q2 revenue <$100M OR book-to-bill <1.3x OR new dilution announced → downgrade to Underweight, trim 25-50%
Specific Golden Dome task-order award announced → orthogonal, +$50M backlog typically translates to 5-10% upside
My final synthesis: Hold is correct. Position weight 1-3% maximum. Pre-commitment plans are mandatory. The disagreement between Aggressive and Conservative is about whether to add 0.5% at $9.64 or wait for $7.50 — that's a 25% expected-value difference on a position size that is already capped at 3%. The strategic call is settled; the tactical call is a manager-level discretion.
Round 2
toward the middle. The Aggressive accepted that 1% additional exposure with discipline is the right move (not 2.5% as initially proposed). The Conservative accepted that $7.50-$8.00 is a more realistic entry than $5.50-$6.50. The disagreement now is on whether to allow the add at $7.50-$8.00 conditionally (Conservative) or unconditionally (Aggressive). Both are reasonable framings.
My final synthesis: the trader's Hold is correct, position weight 1-3% maximum, with conditional add discipline at $7.50-$8.00 contingent on (a) no negative Q2 pre-announcement, (b) no new lockup-acceleration disclosure, (c) macro defense-tech tape remaining supportive. The pre-commitment plans for the August 5 Q2 print are mandatory. Hard stop at $5.50 — below the 50-day SMA convergence area and giving meaningful technical room without being so wide that it stops being a stop.
This is a name where position-sizing discipline is more important than directional conviction. Beta 2.42 means a 30% drawdown is a 1-standard-deviation event, not a tail event. Size accordingly.
Technical Read
Price · 50/200 SMA · Bollinger 20·2 envelope. Levels rail at right is colour-coded — green = support, red = resistance, taupe = neutral.
Indicator Snapshot
RSI(14)
51.1
NEUTRALMid-band
MACD(12·26·9)
-0.12
BEARISHBelow signal
MA stack
+2.3%
BULLISHP > 50 > 200
Volume
1.22x
WARNINGVolume expanding
Realized vol
117%
BEARISHVery elevated
Bollinger %B
48%
NEUTRALMid-band
Price $9.64 sits between $8.30 support and $10.04 resistance; MACD below signal.
Analyst Reports
Market Analysis
Last Close (2026-05-06): $9.64 | 52-Week Range: $4.87 – $22.25 | Beta: 2.42
Redwire (RDW) is a high-volatility small-cap aerospace and defense name that just survived a binary-event tape: the Q1 2026 print on May 6 missed top-line consensus by 7.3% but reaffirmed FY26 revenue guidance at $475M midpoint and disclosed record backlog of $498.1M with a book-to-bill of 1.92x. The session-day volume of 30.2M shares (vs. ~18M average) with an intra-day range of $8.65 → $9.76 is classic post-print capitulation-and-snap-back behavior — sellers exhausted on the open, dip-buyers stepped in on the backlog disclosure.
Trend Structure
The stock entered the print near the 50-day moving average (~$9.43) and the 200-day moving average (~$9.12), a tight clustering that signaled an unstable equilibrium even before earnings. Pre-print, price was 56.7% off the 52-week high of $22.25 but +97.9% above the 52-week low of $4.87 — a wide-range basing pattern after the late-2025 selloff. Post-print, the May 6 close at $9.64 reclaims both moving averages by a thin margin.
Volume & Distribution
The five-session run-up to the print:
2026-04-29: $8.98 → $8.60 on 14.8M (capitulation low)
2026-04-30: $8.81 → $9.19 on 14.4M (bounce)
2026-05-01: $9.29 → $9.34 on 14.9M (consolidation)
2026-05-04: $9.14 → $8.64 on 22.7M (pre-print de-risking)
2026-05-05: $8.88 → $8.69 on 22.6M (more de-risking)
2026-05-06: $8.81 → $9.64 on 30.2M (post-print snap-back)
This is a textbook buy-the-rumor-sell-the-fact-buy-the-real-news sequence. Smart money pre-positioned short into the print, covered on the EPS miss, and then re-bought on the backlog and book-to-bill disclosures.
Volatility Profile
Beta of 2.42 makes RDW one of the highest-volatility names in the small-cap aerospace and defense complex. Q1 ATR has been running $0.40-$0.50 — translating to 4-5% daily ranges, the kind of name where stop-loss discipline matters more than entry precision. Given the range from $4.87 to $22.25 over 12 months, a single-event move of 15-25% is the base case, not the outlier.
Mid-Jan 2026 spike high on Golden Dome inclusion (+15.7% session)
$10.04
Resistance
Recent bounce-fail price; first overhead test
$9.64
Reference
2026-05-06 last close
$9.43
Pivot
50 SMA — flip line for short-term trend
$9.12
Pivot
200 SMA — major test for medium-term posture
$8.30
Support
May 5 intraday low
$4.87
Support
52-week low — terminal floor
Outlook
The May 6 reversal is constructive but not confirmation. The setup needs a follow-through close above $10.00 on volume to argue the post-print bottom is in. A daily close back below $8.30 invalidates the bounce and opens $7.50-$8.00 air. Given beta of 2.42 and the structural overhang from the $530M follow-on equity issuance, this is not a name to chase on a single green candle — wait for the volume-weighted reclaim of $10 or accumulate on a re-test of $8.50 with confirmation.
The technical thesis is constructive on a 6-12 month horizon if the backlog conversion shows up in Q2-Q3 2026 revenue and EBITDA, bearish near-term if dilution re-accelerates or Golden Dome contract-flow disappoints. ATR-adjusted position sizing is mandatory.
Signal
Reading
Bias
Trend (50/200)
Reclaiming both, marginal
Neutral
Volume
30M session on post-print rally
Constructive
52w Position
-56.7% from high, +97.9% from low
Asymmetric
ATR / Beta
Beta 2.42, ATR 4-5% daily
High vol
Backlog Print
$498.1M record / B2B 1.92x
Constructive
EPS Miss
-$0.40 vs -$0.15 est
Bearish
Equity Issuance
$530M follow-on overhang
Bearish
Social Sentiment
The investor conversation around Redwire over the April-May 2026 window is dominated by two competing narratives that intersected at the May 6 print: a defense-tech disruptor riding the Golden Dome and Pentagon drone-procurement tailwinds, versus a serially loss-making small-cap that just diluted shareholders by $530M while missing top and bottom line consensus.
Headline Sentiment
The most frequent framing in coverage is "high-conviction speculative defense play." 24/7 Wall Street's "Defense Stocks Worth Buying Under $15" piece (May 4) captured the dominant retail thesis: drones plus space infrastructure plus political tailwinds across both parties heading into mid-2026, expressed via small-cap names without the multi-decade legacy of the mega-cap primes. The Motley Fool's space-earnings-day framing (May 6) explicitly grouped RDW with BlackSky and Rocket Lab as the "SpaceX-IPO-alternative" basket. H.C. Wainwright reiterated its Buy with explicit references to Golden Dome 2026 awards and the Army Long-Range Reconnaissance program as the next two catalysts.
Bearish Counter-Narrative
Three threads dominate the bear case:
Q1 miss and dilution coverage — Zacks ("Reports Q1 Loss, Lags Revenue Estimates"), StockStory ("Sales Below Analyst Estimates In Q1 CY2026 Earnings, Stock Drops 10.5%"), and Simply Wall Street ("Revenue Jumps But Losses Deepen And Equity Issuance Grows") all framed the print as a high-growth, low-quality story. Revenue missed by 7.3% and GAAP EPS missed by ~165%. The $530M of follow-on equity issuance is the structural overhang.
AE Red Holdings 2.7M-share insider sale at $28.4M (~$10.50/share) — the Motley Fool flagged this April 24 transaction with the framing "should you drop the stock?" This is the kind of disclosure that rebrands a name from "asymmetric upside" to "insider exit."
3 Small-Cap Stocks We Approach with Caution — StockStory included RDW in its caution list, citing valuation discipline concerns at the small-cap end of the defense complex.
Bullish Counter-Narrative
Three offsetting bull threads:
Record backlog and book-to-bill — the $498.1M backlog and 1.92x book-to-bill ratio is the single most credible bull data point. For an aerospace/defense name, book-to-bill above 1.5x is the threshold of "structural growth"; above 1.8x is "demand exceeds supply".
Golden Dome inclusion — the late-January 2026 stock surge of +29% on inclusion in the $151B umbrella contract framework set the tone for the year. RDW's inclusion is not exclusive (it's one of dozens of tier-2 contractors), but it confirms the integrator-level relevance.
Edge Autonomy combat-validated drones — the Penguin UAS in Ukraine is real-world demonstration of platform credibility, which matters for procurement officers pricing risk on novel suppliers.
Insider Activity
Insider transactions through Q1 are unambiguously net-selling:
AE Red Holdings (former owner of Edge Autonomy entities tied to RDW) — 2.7M shares sold at $28.4M (~$10.50/share) in late April 2026
Smaller officer sales spread across February-March 2026
The AE Red transaction is the structural overhang. AE Red came into RDW via the Edge Autonomy stock-deal consideration ($775M of the $925M purchase price was stock); the share lockup expirations are now in play, and the 2.7M sale is plausibly only the first tranche.
Social Topology
Retail sentiment on social platforms (X, Stocktwits, Reddit r/SpaceStocks) is mixed-with-bullish-bias — the Golden Dome narrative remains the dominant hook, and the May 6 print did not break it. The institutional sentiment as expressed through analyst price targets is wider and more bearish than retail — RDW Public.com forecasts show a price target range of $8 to $24, a 3x dispersion that reflects genuine analyst disagreement on whether this is a defense-tech compounder or a serially-loss-making cash-burner.
Read
Sentiment is bipolar, with the bull narrative anchored on backlog, Golden Dome, and combat-validated drone IP, and the bear narrative anchored on dilution, EPS misses, and insider lockup overhangs. The bull narrative is winning at the print level (May 6 reversal); the bear narrative is winning at the chart level (52-week drawdown of -56.7%). This is exactly the sentiment posture you see at a small-cap defense name that could be a 2-3x in 18 months or a -50% in 6 — the dispersion is the signal.
Theme
Tone
Weight
Golden Dome contract umbrella
Bullish
High
Edge Autonomy / drone platform
Bullish
High
Record backlog + book-to-bill 1.92x
Bullish
High
Q1 EPS miss / dilution
Bearish
High
Insider sales (AE Red Holdings 2.7M)
Bearish
Medium
Defense stocks under $15 retail bid
Bullish
Medium
Small-cap caution / valuation noise
Bearish
Low
News & Macro
The macroeconomic and industry backdrop driving the RDW tape over the past month is dominated by three intersecting forces: a multi-year US defense budget tailwind that is starting to operationalize at the line-item level, a small-cap defense-tech rotation as institutional money seeks asymmetric upside outside the mega-cap primes, and a capital-markets environment that is still penalizing serially loss-making issuers despite supportive narratives.
Defense Budget Cycle and Golden Dome
The Pentagon's $1.5T FY27 budget submission (per the Sirotin Intelligence Briefing, April 20-24, 2026) explicitly operationalizes the Golden Dome missile-defense framework. RDW joined the $151B Golden Dome umbrella contract in late January 2026, triggering a +29% session-day rally. The structure of the contract umbrella is critical: it is not an exclusive award to any single contractor, but a multi-year IDIQ vehicle that requires individual task-order awards to convert into revenue. The first major tracking-layer award — the SDA Tranche 3, $3.5B for 72 satellites — went to Lockheed Martin, L3Harris, Northrop Grumman, and Rocket Lab USA. RDW was not on the prime list. That said, RDW's positioning as a sub-tier component supplier (sensors, payloads, satellite buses for smaller orbital nodes) remains intact, and the Space Force's planned multi-billion FY27 Space Data Network investment opens additional addressable opportunity.
Small-Cap Defense Rotation
The 24/7 Wall Street "Defense Stocks Worth Buying Under $15" thesis (May 4) is part of a broader institutional rotation. After 18 months of mega-cap defense (LMT, NOC, GD, RTX) compounding at single-digit rates with full multiples, the search for asymmetric upside has shifted to the $1-3B market-cap tier — RDW ($1.92B), Kratos ($KTOS), AeroVironment ($AVAV), Mercury Systems ($MRCY), and similar names. The driver is the structural shift in DoD procurement toward autonomous systems, tactical drones, and disaggregated space architectures — precisely the categories where the legacy primes have catch-up R&D rather than productized leadership.
Q1 Earnings Print Reset
RDW's May 6 Q1 print was a binary event for the small-cap defense-tech complex. Revenue grew 57.9% YoY but missed consensus by 7.3%; GAAP EPS missed by 165%. However, the FY26 revenue guide ($450-500M, midpoint $475M) was reaffirmed and is 0.8% above prior consensus, gross margin improved 26.6% sequentially, and book-to-bill of 1.92x was disclosed for the first time. The early bear reaction (-10.5% intraday) reversed by the close as the backlog data hit the tape. This kind of mixed print is the new default for high-growth small-cap defense-tech: near-term execution noise, but the long-term order book remains directionally constructive.
Edge Autonomy and Combat-Validated Drones
The Edge Autonomy acquisition ($925M, $150M cash + $775M stock, closed mid-2025) remains the central transformation in RDW's identity. The Penguin UAS — Edge Autonomy's flagship Group 2 UAS — has been deployed with Ukrainian forces against Russia, providing combat-validated capability that DoD procurement officers explicitly value. The acquisition gave RDW a Pentagon-relevant drone platform without years of internal development, but at the cost of substantial dilution (the $775M stock consideration roughly doubled the share count). The Q1 2026 share count of 191.9M (up from 67.0M at year-end 2024) reflects this structural shift.
Capital Structure and Equity Issuance
The $530M follow-on equity raise in Q1 2026 (multiple tranches, at-the-market and structured offerings) is the largest single equity issuance in RDW's public history. It is supportive of the long-term capital build (R&D, manufacturing capacity, working capital for backlog conversion), but it is also the single most significant overhang on the share price until the backlog conversion shows up in revenue and EBITDA. With ~192M shares now outstanding versus 67M at end-2024, the dilution math has been brutal: book value per share has declined faster than the absolute book value has grown.
Macroeconomic Backdrop
Geopolitical context remains supportive: ongoing Russia-Ukraine conflict, Middle East tensions, and Indo-Pacific tensions all justify continued elevated defense spending. The political alignment for defense spending across both parties heading into mid-2026 is the rare item of bipartisan consensus. Tariff exposure is moderate — RDW manufactures primarily in the US (with European footprint via Edge Autonomy in Latvia/Estonia) — but supply-chain inputs (rare earths, semiconductors, specialty alloys) are exposed to global trade frictions.
Read
The macro tape is structurally bullish on small-cap defense-tech and operationally noisy on RDW specifically. The Golden Dome umbrella is a real catalyst, but conversion to RDW-specific revenue requires individual task orders that haven't yet been disclosed. The Edge Autonomy thesis is real but at the cost of dilution that hasn't yet been earned back through EBITDA. The Q1 print was mixed but not thesis-breaking. Net: this is a name where 12-18 month asymmetry is real, but 90-day execution risk is non-trivial.
Theme
Macro Tone
Weight
Pentagon FY27 budget operationalization
Positive
High
Golden Dome umbrella inclusion
Positive
High
SDA Tranche 3 (RDW not prime)
Negative-neutral
Medium
Small-cap defense-tech rotation
Positive
High
Q1 EPS miss / dilution overhang
Negative
High
Edge Autonomy combat validation
Positive
Medium
FY26 guide reaffirmed
Modestly positive
Medium
Geopolitical risk environment
Positive
Medium
Equity issuance overhang ($530M)
Negative
High
Fundamental Analysis
Redwire Corporation occupies the rare and difficult intersection of rapid revenue growth with persistent operating losses, a fortress backlog with a fragile balance sheet, and a transformational acquisition with severe dilution. The Q1 2026 print on May 6 was the first opportunity to assess the post-Edge-Autonomy combined entity at scale, and the data tells a story of demand confirmation alongside execution-and-financing risk that the market has not yet resolved.
Top-Line Engine
Q1 2026 revenue: $96.97M (+57.9% YoY vs $61.4M Q1 2025) — driven primarily by the inclusion of Edge Autonomy operations and a partial sequential ramp in legacy space contracts. Revenue missed consensus by 7.3% ($104.6M expected). The full-year 2026 guide was reaffirmed at $450M-$500M, midpoint $475M, which is 0.8% above prior consensus.
Trailing twelve-month revenue: $335.4M (up from ~$305M in the year-ago period; the Edge Autonomy contribution started in mid-2025 so TTM is not yet a full-year combined view). The pro-forma annualized revenue run-rate based on Q1 alone is ~$388M, suggesting Q2-Q4 acceleration is required to hit the $475M midpoint — the backlog conversion is the central operational question.
Margin Structure (Q1 2026 vs prior periods)
Metric
Q1 2026
Q4 2025
Q1 2025
Q1 YoY Δ
Total Revenue
$96.97M*
$108.79M
$61.40M
+57.9%
Gross Profit
n/a*
$10.50M
$9.04M
n/a
Gross Margin
26.6%
9.6%
14.7%
+1190 bps YoY
Operating Loss
n/a*
-$46.82M
-$10.52M
-
Net Loss
-$76.5M†
-$85.47M
-$2.95M
-
Diluted EPS
-$0.40
-$0.58
-$0.09
-
*Q1 2026 detail: from press disclosures. †Net loss combines net income + preferred dividends.
The gross margin improvement to 26.6% is the most constructive operational data point in the print. Versus Q4 2025's 9.6% and Q1 2025's 14.7%, the sequential and YoY expansion suggests product-mix shift toward higher-margin Edge Autonomy drone platforms and improving fixed-cost absorption as revenue scales. Critical to the bull thesis: gross margin 26-30% is the floor for plausible operating-leverage to break-even at $600M-$700M revenue scale.
Backlog & Book-to-Bill (Forward Indicator)
Record backlog: $498.1M (Q1 2026 disclosure)
Space segment: ~$300M
Defense Tech: ~$200M
Book-to-bill ratio: 1.92x — exceptionally strong
For a defense-tech name at this scale, a book-to-bill of 1.92x is the single most credible forward indicator. Above 1.5x is structural growth; above 1.8x is demand-exceeds-supply; above 2.0x is a capacity-constrained name. RDW is in the demand-exceeds-supply zone. The challenge is execution: converting backlog to revenue requires manufacturing scale-up and program-delivery discipline that has historically been the cost-overrun pinch point for small-cap aerospace names.
Customer Concentration & Mix
Per the 2025 10-K (filed early 2026):
National Security: 46.9% of revenue (DoD, intelligence community, allied governments)
Civil: 21.6% (NASA, ESA, civilian space programs)
Commercial: 31.5% (commercial satellite operators, station modules, in-space manufacturing)
41.6% of revenue is non-US (significant international exposure, particularly through Edge Autonomy's European operations)
No single customer disclosed at >10% of revenue, but the DoD aggregate exposure is the dominant concentration. Customer-segment shifts driven by the Edge Autonomy integration are now pushing the defense mix higher — accretive to margin but more dependent on appropriations and political continuity.
Balance Sheet & Capital Structure
Metric
2025-12-31
2024-12-31
Δ
Total Assets
$1,449M
$293M
+$1,156M (Edge close)
Total Debt
$124M
$145M
-$21M
Cash + ST investments
$95M (EOP)
$49M
+$46M
Stockholders' Equity
$1,137M
-$52M
+$1,189M (equity issue)
Goodwill + Intangibles
$1,115M
$133M
+$982M (Edge premium)
Shares Outstanding (Basic)
191.9M
66.3M
+125.6M (+189%)
Debt-to-Equity
0.11
-2.79
Normalized
Key observations:
The Edge Autonomy acquisition added ~$982M of goodwill+intangibles — i.e., the deal was priced significantly above book.
Share count nearly tripled from year-end 2024 to year-end 2025 (66.3M → 191.9M), and continues to drift higher in Q1 2026 (192.95M issued).
Cash position improved modestly to $95M EOP 2025 from $49M EOP 2024, but TTM free cash flow was -$120M, so the cash is net-funded by equity issuance, not operations.
Working capital of $97M is adequate but not buffer-rich for a name burning ~$30M/quarter at the FCF line.
Cash Generation
Q4 2025 free cash flow: -$30.1M. TTM free cash flow: -$200.6M. This is a cash-burning name. The path to cash-flow neutrality requires:
Continued gross-margin expansion to 30%+
SG&A leverage as revenue scales toward $600M+
R&D intensity normalization (Q1 2026 R&D was 9.8% of revenue, sustainable for now)
Until cash burn inflects, the share-issuance machinery remains active — that is the dilution overhang.
Valuation Backdrop
Market cap: $1.92B
Enterprise value: ~$1.95B (debt $124M minus cash $95M)
Price/Book: 1.74x — among the lowest readings in 2 years
For a defense-tech name with 50%+ revenue growth, 4.1x forward EV/Sales is reasonable and arguably below peer. Comparable small-cap defense-tech names (Kratos at ~3.5x, AeroVironment at ~5x, BlackSky at higher EV/Sales) bracket the multiple. The case for re-rating depends entirely on demonstrating that backlog converts to revenue and gross margins continue expanding.
Quality & Returns
ROE: -41.8% (negative; reflects ongoing losses)
ROA: -11.5%
Profit margin: -67.6% (TTM, distorted by stock-based comp and integration charges)
Operating margin: -43.0%
Beta: 2.42 — among the most volatile aerospace/defense names in the listed universe
This is not a quality compounder; it is a growth-velocity story with high optionality and high dilution risk.
Forward Look
Management guidance: FY26 revenue $450-500M, Adjusted EBITDA implied range likely $20-50M based on the gross margin trajectory. The path to reaching this guide requires:
Q2-Q3 revenue ramp to ~$120M+ per quarter
Backlog conversion velocity acceleration
No further dilutive equity raises (or at least no material ones)
At least one Golden Dome task-order award disclosure
The bull case is 2x re-rating to ~$15-19/share over 12 months if the FY26 guide is delivered, gross margin holds 26-30%, and the $498.1M backlog converts at 4-quarter velocity. The bear case is another 25-40% drawdown to $5-7 if Q2 misses, gross margin compresses, or another $200M+ equity raise is announced.
Metric
Reading
Verdict
Revenue growth (Q1 YoY)
+57.9%
Excellent
FY26 guide
$450M-$500M
Reaffirmed, modestly above
Backlog
$498.1M record
Excellent
Book-to-bill
1.92x
Exceptional
Gross margin
26.6% (Q1 2026)
Inflecting positive
Operating cash flow
Negative
Concerning
Share count
191.9M (+189% YoY)
Severe dilution
Net debt / EBITDA
meaningless (neg EBITDA)
High structural risk
Forward EV/Sales
4.1x
Reasonable for growth
Beta
2.42
High volatility
The fundamental verdict: demand-side excellent (backlog, growth, mix), execution-side mixed (margin trajectory positive but EPS misses), capital-side fragile (recent dilution, no cash-flow visibility). This is a 3-5% portfolio position for the right risk profile, 0% for capital-preservation mandates.
Risk Factors (Item 1A)
Top Item 1A Risk Factors — Redwire Corporation (10-K filed early 2026; fiscal year ended 2025-12-31)
Filing reference: Redwire 10-K filing for FY2025, available via investor relations page at ir.redwirespace.com/sec-filings
Heavy dependence on US government contracts. 46.9% of FY25 revenue came from national security customers and 21.6% from civil agencies (NASA, ESA), giving roughly 68.5% government-related revenue concentration. Continued congressional appropriations risk, contract-funding-cycle disruption, and the operationalization of Continuing Resolutions all directly affect revenue cadence. The Edge Autonomy acquisition further concentrated this exposure.
Material weaknesses in internal control over financial reporting. The 10-K disclosed identified material weaknesses in ICFR, primarily around acquired-business integration controls (Edge Autonomy) and revenue-recognition cutoff. Material weaknesses raise the cost of audit, can delay future filings, and increase the probability of restatement events.
Customer concentration at the segment level. While no single customer is >10% of revenue, the DoD aggregate is the dominant counterparty and discretionary appropriations risk is the largest single-event tail. Loss of a major program win or a contract-protest reversal can disproportionately impact backlog conversion.
Acquisition integration risk and goodwill impairment exposure. The Edge Autonomy acquisition added ~$982M of goodwill and other intangibles to the balance sheet — roughly 67% of total assets. A program execution failure, customer concentration shift, or regulatory action affecting the drone export business would trigger goodwill impairment review and potential write-downs.
Heavy reliance on equity capital markets and dilution risk. RDW is cash-burning at the FCF line (-$120M TTM). The Q1 2026 follow-on offerings raised $530M but increased share count by approximately 25% in a single quarter. Continued operating losses and program-investment requirements imply additional dilution risk over the next 12-18 months.
Export controls and ITAR exposure. Edge Autonomy's drone platforms (Penguin and others) are subject to US export-control regulations including ITAR. The 10-K explicitly cites export-control compliance and tariff pressures as material risks. Mistakes in export-control compliance can trigger criminal penalties, contract debarment, and shareholder litigation.
Competition from larger and foreign-supported rivals. RDW competes against legacy primes (Lockheed Martin, Northrop Grumman, L3Harris) with deeper balance sheets and longer customer relationships, and against foreign-supported competitors (notably Chinese and European space-systems vendors) that benefit from state subsidies. The SDA Tranche 3 award going to LMT/L3H/NOC/RKLB rather than RDW is a recent example of this competitive dynamic.
Cybersecurity and supply-chain integrity. As a DoD-cleared supplier of space and drone platforms, RDW faces both the targeted cyber risk of nation-state adversaries seeking to exfiltrate IP, and the supply-chain risk of compromised semiconductor or specialty-alloy components. The 10-K cites cybersecurity as a material risk, and a successful intrusion could lead to clearance suspension and contract loss.